En español
NIDA

CTN Dissemination Initiative

Revised May 2018

CTN Dissemination Initiative Logo

The CTN Dissemination Initiaive aims to reduce the gap that exists between the publication of research on treatment of substance use disorders and implementation in clinical practice. Please explore the links below to learn more abou the iniative and our products.

Products and Materials

Products constitute a primary mode of research translation toward clinical practice in the drug abuse field. We work with NIDA researchers, treatment practitioners, subject matter and communications experts to develop training curricula, manuals, tools, and other resource materials based on NIDA-supported research.

Adolescent Substance Use Screening Tools
Blending Initiative Health Risk Behaviors
CTN Blending Initiative - Engaging Adolescent Patients About Marijuana Use
Meetings and Conferences

Another cornerstone of the CTN Dissemination Initiative involves the planning and execution of Meetings and Conferences. These unique events provide an opportunity to foster collaboration and knowledge exchange between drug abuse researchers and treatment providers. The events expose providers to cutting-edge, evidence-based treatments and offer continuing education credits for physicians, psychologists, nurses, physician assistants, social workers, and addiction counselors. With the support and involvement of NIDA researchers, federal partners, and professional organizations, the Initiative has been advanced through a variety of hands-on, skill-building workshops and lectures for audiences ranging from addiction professionals to emergency department physicians. These activities also serve as opportunities for us to meet with leadership and members of key organizations to initiate collaborative training activities, discuss partnership possibilities, and initiate resource development.

Mentored Training Awards

The CTN Dissemination Initiative aims to establish and maintain collaborative partnerships with professional organizations serving the addiction treatment community as well as general medical settings such as primary and emergency care. In recent years, the Initiative has partnered with more than a dozen organizations to provide embedded conference sessions, preconference workshops, and specialty courses, along with training and mentorship awards. These collaborations are key to reaching the full spectrum of healthcare providers and professionals, as well as reaching health providers just beginning their career trajectory. One facet of the Initiative’s efforts at collaboration is the distribution of resident mentorship opportunities with professional organizations. These mentoring activities create unique opportunities to encourage the early adoption and implementation of evidence-based substance use disorder treatment interventions in the general healthcare setting.

Past NIDA/SAMHSA Blending Initiative
Blending Initiative Banner

About the Blending Initiative:

Accelerating the dissemination of research-based drug abuse treatment into clinical practice is a priority for the National Institute on Drug Abuse (NIDA) and represents the core mission of the Blending Initiative. NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA) joined together to create the Blending Initiative in 2001 to reduce the gap that exists between the publication of research results and impact on treatment delivery. This initiative incorporates collaboration between clinicians, scientists, and experienced trainers to catalyze the creation of user-friendly treatment tools and products and facilitate the adoption of research-based interventions into front-line clinical settings. Through this initiative, NIDA and SAMHSA’s Addiction Technology Transfer Centers (ATTCs) disseminate treatment and training products based on results from studies conducted by the National Drug Abuse Clinical Trials Network (CTN) as well as other NIDA-supported research.  For additional information on the Blending Initiative, contact:

Joanna Weston, MPH
Email: JWeston@leedmci.com

The Blending Initiative comprises three components:

  • Blending Products and Materials;
  • Blending Meetings and Conferences; and
  • Collaborative Partnerships

Through these components, and together with SAMHSA, NIDA facilitates the adoption of research-based interventions into front-line clinical settings.

Products & Materials:

NIDA Blending Products and Materials constitute a primary mode of research translation toward clinical practice in the drug abuse field. Blending Teams, consisting of NIDA researchers, treatment practitioners, trainers from SAMHSA’s ATTC Network, NIDA staff, and subject matter and communications experts, work closely together to develop training curricula, manuals, tools, and other resource materials based on NIDA-supported research. Blending Products introduced into the field have covered such topics as Motivational Interviewing, HIV Rapid Testing, Motivational Incentives/Contingency Management, and Buprenorphine Treatment for Opioid Use Disorders. Recent efforts have included an infographic on the role of Smoking Cessation in Addiction Treatment, along with web-based simulation training for Motivational Interviewing.  

Covers of Buprenorphine and HIV Testing products

Meetings & conferences:

Another cornerstone of the Blending Initiative involves the planning and execution of Blending Meetings and Conferences. These unique events provide an opportunity to foster collaboration and knowledge exchange between drug abuse researchers and treatment providers. The events expose providers to cutting-edge, evidence-based treatments and offer continuing education credits for physicians, psychologists, nurses, social workers, and addiction counselors. With the support and involvement of NIDA researchers, federal partners, and professional organizations, the Blending Initiative has been advanced through a variety of hands-on, skill-building workshops and lectures for audiences ranging from addiction professionals to emergency department physicians. These activities also serve as opportunities for Blending Teams to meet with leadership and members of key organizations to initiate collaborative training activities, discuss partnership possibilities, and initiate resource development.

Collaborative Partnerships:

The Blending Initiative aims to establish and maintain collaborative partnerships with professional organizations serving the addiction treatment community as well as general medical settings such as primary and emergency care. In recent years, the Blending Initiative has partnered with more than a dozen organizations to provide embedded conference sessions, preconference workshops, and specialty courses for buprenorphine credit waivers, along with training and mentorship awards. These collaborations are key to reaching the full spectrum of healthcare providers and professionals, as well as reaching health providers just beginning their career trajectory. One facet of the Blending Initiative’s efforts at collaboration is the distribution of resident mentorship opportunities. Beginning in 2012, the Blending Initiative began partnerships with a variety of organizations to facilitate the funding and management of these opportunities. Such organizations include the American Academy of Child and Adolescent Psychiatry, the American College of Emergency Physicians, the Society of Teachers of Family Medicine, and the Society for Adolescent Health and Medicine. These mentoring activities create a fantastic opportunity for NIDA and the Blending Initiative to encourage the early adoption and implementation of evidence-based substance use disorder treatment interventions in the general healthcare setting.

About the CTN Dissemination Initiative

Accelerating the dissemination of research-based drug abuse treatment into clinical practice is a priority for the National Institute on Drug Abuse (NIDA) and represents the core mission of the Clinical Trials Network (CTN) Dissemination Initiative.  This initiative incorporates collaboration between clinicians, scientists, and experienced trainers to catalyze the creation of user-friendly treatment tools and products and facilitate the adoption of research-based interventions into front-line clinical settings. 

The Initiative comprises three components by facilitating the adoption of research-based interventions into front-line clinical settings.

  • Products and Materials;
  • Meetings and Conferences; and
  • Collaborative Partnerships

This page was last updated May 2018

Get this Publication

    National Drug Abuse Treatment Clinical Trials Network: Search listings of drug abuse clinical trials, click here